Home/Filings/4/0001193805-25-000672
4//SEC Filing

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4

Accession 0001193805-25-000672

CIK 0001374690other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 7:44 PM ET

Size

12.9 KB

Accession

0001193805-25-000672

Insider Transaction Report

Form 4
Period: 2025-05-13
Flynn James E
Director10% OwnerOther
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-13+19,00019,000 total(indirect: Through Deerfield Management Company, L.P.)
    Exercise: $1.88Exp: 2035-05-13Common Stock (19,000 underlying)
DEERFIELD MANAGEMENT CO /NY
Director10% OwnerOther
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-13+19,00019,000 total(indirect: Through Deerfield Management Company, L.P.)
    Exercise: $1.88Exp: 2035-05-13Common Stock (19,000 underlying)
Footnotes (3)
  • [F1]Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").
  • [F2]The option was granted on May 13, 2025 and is scheduled to vest on the earlier of May 13, 2026 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer.
  • [F3]This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001009258

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:44 PM ET
Size
12.9 KB